Page 71 - MemoriaOBN-Eng
P. 71
www.ciberobn.es
• r a, G P, M-G l, r a, V V, r F .. Reduced
Most relevant oDríGuezenaénDeziMénezositoalentíotellaret al
hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-
scientific arti-
alcoholic fatty liver disease.Int J Obes (Lond). 2013 Dec 13;.
cles • n J, h s, h a, l J, V K, s l ..
auKKarineneinonenaKKarainenunDBoMuolteenahoaarinenet al
Characterising metabolically healthy obesity in weight-discordant monozygotic twins.
Diabetología. 2013 Oct 8;.
• o FJ, M JM, c V, M-n JM, P n, s M .. Targeting
rteGaercaDeratalánorenoaVarreteueyoaBateret al
the circulating microRNA signature of obesity.Clin Chem. 2013 May;59(5):781-92.
• catalán V, GóMez-aMBrosi J, roDríGuez a, raMírez B, rotellar F, Valentí V et al.. Increased
levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to
inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral
adipocytes from obese patients.Surg Obes Relat Dis. 2013 Mar-Apr;9(2):306-14.
• Moreno-naVarrete JM, escoté x, orteGa F, serino M, caMPBell M, MichalsKi Mc et al.. A role
for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity- üü
associated adipose tissue dysfunction.Diabetología. 2013 Nov;56(11):2524-2537.
ó
á
Highlights
PROJECTS
• Prospective study of the changes in energy balance after bariatric surgery. ISC III. Minis-
í
ó
terio Economa y Competitividad FIS-INTRASALUD. IP Gema Frühbeck.
• Study of the implication of extracellular matrix remodeling of the adipose tissue and liver í
in the onset of obesity and its comorbidities. ISC III. Ministerio Economía y Competitivi-
ó
dad FIS. IP. Javier Gmez-Ambrosi.
•
Impact of ghrelin isoforms in the development of obesity-related hypertension. ISC III.
Ó
Ministerio Economa y Competitividad FIS. IP Amaia Rodríguez. é
• DORIAN - Developmental Origins of Healthy and Unhealthy Ageing. The role of Maternal
Obesity. EU Commission, 7th Framework Programme. IP Patricia Iozzo.
• SPOTLIGHT – Sustainable Prevention of Obesity Through Integrated Strategies. EU 7th
Í
Framework Programme IP Johannes Brug.
PATENT
ä
• Co-inventor of the patent entitled “Useful molecules for the treatment and/or prevention
Í
of metabolic alterations associated to obesity and insulin resistance” (no P201330998).
LIDERAZGO EN ELABORACIN DE GUAS CLNICAS
• Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts
2013;6:449-68.
• Obesity: The Gateway to Ill Health – an EASO Position Statement on a Rising Public
Health, Clinical and Scientific Challenge in Europe. Obes Facts 2013;6:117–120.
í
COLLABORATIONS
• Predoctoral training of a member of the CIBERobn group Obesidad, Neuroendocrinología
y Funcin Reproductora in the Metabolic Research Laboratory. Collaboration between Cór-
doba and Pamplona nodes.
í13
• Collaborations & publications with the CIBERobn groups of Drs. Casanueva, Fernández-
0
2
Real, Fernndez-Aranda, Diguez, Tena-Sempere, Botella, Argente, Tinahones Villaroya. RT
• International collaborations with Drs. Pietilinen (Helsinki, Finland) and Calamita (Bari, Italy).
PO
E
AWARDS R
AL
• Albert Struyvenberg Medal 2013 of the European Society for Clinical Investigation (Gema
U
Frhbeck) NN
A
• EASO Young Investigator Award in Basic Science 2013 (Amaia Rodrguez) /
BN
• SEEDO Basic Research Award in Obesity 2013 (Amaia Rodrguez)
O
ER
BOOK CHAPTER B
• Frhbeck G, Gmez-Ambrosi J. Adipose tissue. In: Encyclopedia of Human Nutrition 3rd
CI
Edition. Eds: Caballero B, Allen L, Prentice A. Elsevier Ltd., Oxford, United Kingdom, 2013 71
pages 1-14. (ISBN: 978-0-12-375083-9).
